Search clinical trials for: adalimumab-US source

Total 2079 results

Boehringer Ingelheim

Completed

Pharmacokinetics and Safety in Healthy Volunteers

Healthy

Belgium, New Zealand
Samsung Bioepis Co., Ltd.

Completed

Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB5 in Healthy Subjects

Healthy

Germany
Synermore Biologics Co., Ltd.

Completed

Comparison of the Safety and PK of SYN060 to Humira® in Healthy Adult Subjects

Arthritis, Rheumatoid

Australia
Pfizer

Completed

A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07)) (B538-07)

Healthy Subjects

United States
Pfizer

Completed

Study Of PF-06410293 And Adalimumab In Healthy Subjects (REFLECTIONS B538-01)

Healthy

United States, Belgium
Sinocelltech Ltd.

Completed

Pharmacokinetics and Safety in Healthy Volunteers

Healthy

China
Sandoz
Hexal AG

Completed

Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis (ADMYRA)

Rheumatoid Arthritis

United States, United Kingdom, Hungary, Italy, Malaysia, Serbia, Mexico, Spain, Czechia, Poland, Germany, Romania, Russian Federation
EirGenix, Inc.

Completed

A Pharmacokinetic Study Comparing EG12014 and Herceptin (Trastuzumab) in Healthy Male Volunteers

Healthy
mAbxience Research S.L.

Completed

A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva

Healthy Volunteers

Poland
Samsung Bioepis Co., Ltd.

Completed

Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

Arthritis, Rheumatoid

Spain, United States, Korea, Republic of, Malaysia, Poland, Thailand, Bulgaria, Chile, Estonia, Germany, Hungary, New Zealand, Russian Federation, Serbia, Ukraine
Enzene Biosciences Ltd.
Alkem Laboratories Ltd

Recruiting

Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers

Healthy Male Subjects

Bulgaria, Poland
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11022 in Healthy Subjects

Healthy Subjects
Prestige Biopharma Limited

Recruiting

To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects

Healthy Volunteers

Spain
Mylan Inc.
Mylan GmbH

Completed

Adalimumab PK Bioequivalence Study to EU and US Sourced Humira

Healthy Volunteers

Belgium
Celltrion

Completed

To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects

Healthy

Korea, Republic of
Stanford University
Medical Research Council, South Africa; African Institute for Health and Development...

Completed

A Cluster-randomized Trial to Assess a Sexual Assault Prevention Intervention in Adolescents in Nairobi, Kenya

Violence, Non-accidental | Sexual Assault and Rape

Kenya
Shanghai Henlius Biotech

Recruiting

A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects

Healthy Male Volunteers

China
Samsung Bioepis Co., Ltd.

Recruiting

A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy

Non-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage II

Korea, Republic of, Poland, Spain, Turkey
Catharina Ziekenhuis Eindhoven
Eindhoven University of Technology

Unknown

3D US Guided Femoral Artery Access for TAVI (3D-US-TAVI)

Ultrasound Therapy; Complications | Femoral Artery Injury

Netherlands
Shanghai Henlius Biotech

Completed

A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects

Healthy

China
Shanghai Henlius Biotech

Active, not recruiting

A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX15 With Daratumumab in Male Subjects

Multiple Myeloma

China
Samsung Bioepis Co., Ltd.

Completed

Pharmacokinetic, Safety, Tolerability, and Immunogenicity Study of SB8 in Healthy Male Subjects

Healthy

Belgium
Bio-Thera Solutions

Completed

Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects

NSCLC

New Zealand
Cipla BioTec Pvt. Ltd.
Quintiles, Inc.

Unknown

PK Bioequivalence Single-dose Safety Tolerability Study in Healthy Male Volunteers to Compare CBT124 & Avastin(EU&US) (CBT124NHV001)

Healthy

New Zealand
Batterjee Medical College

Not yet recruiting

Effect of Phonophoresis on Trigger Points

Trigger Point Pain, Myofascial
British Columbia Children's Hospital
University of British Columbia

Unknown

Automatic Characterization of the Neonatal Hip Using Ultrasound Imaging

Developmental Dysplasia of the Hip

Canada
University Hospital Inselspital, Berne

Completed

Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis (BERNUTIFUL)

Venous Thrombosis | Postthrombotic Syndrome

Switzerland
University of Wisconsin, Madison
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR)

Tumor, Solid

United States
Seno Medical Instruments Inc.

Completed

The PIONEER-01 Study of the Imagio Breast Imaging System

Breast Cancer

United States
Universitätsklinikum Hamburg-Eppendorf
European Union

Completed

Effects of Infra- and Ultrasound on the Brain

Depression | Sleep | Well-being | Cognitive Function | Ultrasound | Brain Function

Germany
Momenta Pharmaceuticals, Inc.
Mylan Inc.

Completed

Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects

Healthy Volunteers

United Kingdom
Rabin Medical Center

Unknown

Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy

Prostate Biopsy

Israel
Abbott

Withdrawn

Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine (ELAN)

Psoriatic Arthritis
UConn Health
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Completed

Ultrasound and Near Infrared Imaging for Breast Cancer Diagnosis and Neoadjuvant Chemotherapy Monitoring

Breast Cancer

United States
Ohio State University Comprehensive Cancer Center

Recruiting

Sexual Orientation and Gender Identity (SOGI) Data Collection Program Implementation and Evaluation (SOGI)

Cancer Surveillance

United States
Benha University

Completed

Placental Vasculature for Prediction of Recurrent Fetal Growth Restriction

Obstetric Complication
Abbott

Completed

Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)

Arthritis, Juvenile Idiopathic

United States, Belgium, Czech Republic, France, Germany, Italy, Slovakia, Spain
Shanghai Henlius Biotech

Completed

Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects

Immune System Disorder

China
Universidad Rey Juan Carlos

Withdrawn

US-guided Percutaneous Electrolysis (EPE®) in Plantar Fasciosis

Plantar Heel Pain, Plantar Fasciosis

Spain
Abbott

Completed

Remission in Subjects With Crohn's Disease, 1 Year Phase (CLASSICII)

Crohn's Disease

United States
Mylan Inc.
Mylan GmbH

Completed

MYL-1401A Efficacy and Safety Comparability Study to Humira®

Psoriasis | Arthritis, Psoriatic

Bulgaria, Estonia, Hungary, Poland, Russian Federation, Ukraine
Abbott

Completed

Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis (DALI)

Rheumatoid Arthritis

Spain
Universidad Nacional de Rosario

Unknown

Group Intervention Empowerment Dementia

Quality of Life | Self Efficacy | Empowerment

Argentina
Turgut İlaçları A.Ş.

Completed

Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects

Healthy Participants

Germany
University of Colorado, Denver
Massachusetts General Hospital; University of Michigan

Completed

Effectiveness and Costs of Remote Monitoring for Clinical Trials

Remote Monitoring

United States
AbbVie (prior sponsor, Abbott)

Completed

The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

United States
Alvotech Swiss AG

Completed

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

Plaque Psoriasis

Poland, Georgia, Iceland, Russian Federation, Ukraine
AbbVie (prior sponsor, Abbott)

Completed

A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety

Rheumatoid Arthritis

United States, Belgium, Czech Republic, Germany, Puerto Rico, Romania, Slovakia
Sandoz
Hexal AG

Completed

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira (ADACCESS)

Plaque Type Psoriasis

United States, France, Bulgaria, Slovakia

Search clinical trials for: adalimumab-US source

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations